Tim Goyder stocks: Check out this $11m explorer that just joined the exclusive list
Nick Sundich, December 14, 2023
The list of 3 so-called Tim Goyder stocks just welcomed a new member in Battery Minerals (ASX:BAT), soon to be Waratah Minerals (ASX:WM1).
Who is Tim Goyder and which companies are so-called Tim Goyder stocks
Tim Goyder is a mining executive and investor who has an estimated net worth of over $1bn. The bulk of this success has been achieved with Liontown Resources (ASX:LTR) and Chalice Mining (ASX:CHN), which both discovered major battery metal deposits in the Kathleen Valley and Julimar deposits. He also has a stake in DevEx Resources (ASX:DEV).
Joining the list is Battery Minerals, a company that is somewhat different to the other companies he holds a stake in. Goyder and Northern Star (ASX:NST) boss Stuart Tonkin participated in a $560,000 placement that gave him a 7.3% stake in he company. Tonkin owns 9.89% having already owned just over 5% prior to the deal.
Battery Minerals (ASX:BAT) share price chart, log scale (Source: TradingView)
Why he bought into Battery Minerals
Obviously, Goyder must see something in this stock that he likes. This company recently acquired a project in NSW’s East Lachlan Ford Belt that lies just 14km from Newcrest’s Cadia Valley mine. This is a project that has had some exploration work while in private hands, although mostly for copper rather than gold, and the results do not go deep. An initial exploration campaign is set for January.
It seems Tim Goyder is the resources sector equivalent of Bevan Slattery, one who can send shares surging just by buying into the stock – as occured with Slattery and Intellihr and Pointerra. If those case studies are any guide, shareholders can expect momentum in the short-term, although whether or not it lasts will depend on whether or not the company delivers on its promises.
What are the Best ASX Stocks to invest in right now?
Check our ASX buy/sell tips
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Paradigm Biopharmaceuticals (ASX:PAR): An osteoarthritis solution that could hit the market within 3 years
If you thought the were plenty of treatments for osteoarthritis already, Paradigm Biopharmaceuticals (ASX:PAR) is a company that has something…
Cann Group (ASX:CAN): Successfully producing GMP medicinal cannabis since 2017
Cann Group (ASX:CAN) is the first company in Australia that was issued a medicinal cannabis license, granted by the Australian…
CET1 ratio: If you invest in ASX bank stocks, here’s why it is an important metric to know
In this article we look at the Common Equity Tier 1 (CET1) ratio – what it is and why it…